| Literature DB >> 33367843 |
Jamie M Walker1,2, Timothy E Richardson1,2,3, Kurt Farrell4,5,6, Megan A Iida4,5,6, Chan Foong7, Ping Shang7, Johannes Attems8, Gai Ayalon9, Thomas G Beach10, Eileen H Bigio11, Andrew Budson12, Nigel J Cairns13, María Corrada14, Etty Cortes4, Dennis W Dickson15, Peter Fischer16, Margaret E Flanagan11, Erin Franklin13, Marla Gearing17, Jonathan Glass17, Lawrence A Hansen18, Vahram Haroutunian19, Patrick R Hof4,5,6, Lawrence Honig20, Claudia Kawas14, C Dirk Keene21, Julia Kofler22, Gabor G Kovacs16, Edward B Lee23, Mirjam I Lutz24, Qinwen Mao10, Eliezer Masliah18, Ann C McKee12, Corey T McMillan25, M Marsel Mesulam11, Melissa Murray15, Peter T Nelson26, Richard Perrin13, Thao Pham27, Wayne Poon14, Dushyant P Purohit4, Robert A Rissman18, Kenji Sakai28, Mary Sano19, Julie A Schneider29, Thor D Stein12, Andrew F Teich30, John Q Trojanowski23, Juan C Troncoso31, Jean-Paul Vonsattel30, Sandra Weintraub11, David A Wolk25, Randall L Woltjer27, Masahito Yamada28, Lei Yu29, Charles L White7, John F Crary4,5,6.
Abstract
Primary age-related tauopathy (PART) is a neurodegenerative entity defined as Alzheimer-type neurofibrillary degeneration primarily affecting the medial temporal lobe with minimal to absent amyloid-β (Aβ) plaque deposition. The extent to which PART can be differentiated pathoanatomically from Alzheimer disease (AD) is unclear. Here, we examined the regional distribution of tau pathology in a large cohort of postmortem brains (n = 914). We found an early vulnerability of the CA2 subregion of the hippocampus to neurofibrillary degeneration in PART, and semiquantitative assessment of neurofibrillary degeneration in CA2 was significantly greater than in CA1 in PART. In contrast, subjects harboring intermediate-to-high AD neuropathologic change (ADNC) displayed relative sparing of CA2 until later stages of their disease course. In addition, the CA2/CA1 ratio of neurofibrillary degeneration in PART was significantly higher than in subjects with intermediate-to-high ADNC burden. Furthermore, the distribution of tau pathology in PART diverges from the Braak NFT staging system and Braak stage does not correlate with cognitive function in PART as it does in individuals with intermediate-to-high ADNC. These findings highlight the need for a better understanding of the contribution of PART to cognitive impairment and how neurofibrillary degeneration interacts with Aβ pathology in AD and PART.Entities:
Keywords: Alzheimer disease; CA2; Cognitive status; Cornu ammonis; Hippocampal subfields; Neurodegenerative disease; Primary age-related tauopathy
Mesh:
Substances:
Year: 2021 PMID: 33367843 PMCID: PMC8453611 DOI: 10.1093/jnen/nlaa153
Source DB: PubMed Journal: J Neuropathol Exp Neurol ISSN: 0022-3069 Impact factor: 3.148